GEN Exclusives

More »

GEN Poll

More »
Jul 08, 2014

FDA Weighs In on Social Media

The FDA recently issued two draft guidances on the use of social medial by pharmaceutical and biotechnology companies. One focuses on presenting risk-and-benefit information for drugs or devices and the other offers advice for dealing with misinformation spread on third-party sites. (For more on this, click here.)

Do you think the FDA needs to have as strict a stance on social media outlets as it does on traditional communication modes of regulatory information?


Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Genetics and Intelligence

Do you believe research on the genetics of intelligence can improve education?

More »